Company Filing History:
Years Active: 1982
Title: Wolfgang Strecker: Innovator in Liver Growth Enhancement
Introduction
Wolfgang Strecker is a notable inventor based in Eichenau, Germany. He has made significant contributions to the field of medical science, particularly in the area of liver growth enhancement. His innovative work has led to the development of a unique drug that has the potential to impact liver regeneration.
Latest Patents
Strecker holds a patent for a drug designed to enhance liver growth and the method of preparing it. This patent describes a factor that increases the number of liver cells through enhanced cell division activity. The factor is obtained by homogenizing the remaining livers of partially hepatectomized animals, followed by acidification to a pH of 5.5, heat treatment at 95 degrees Celsius, and centrifugation of the homogenate. The resulting supernatant contains a neuraminic-acid-free protein with a molecular weight of approximately 30,000 to 50,000 Daltons. Additionally, an extract containing this factor can also be derived from the blood plasma of hepatectomized animals when treated with neuraminidase. Furthermore, similar extracts can be obtained from the livers or plasma of non-hepatectomized fetal or very young animals.
Career Highlights
Strecker is associated with the Max Planck Society for the Advancement of Science, a prestigious research institution known for its contributions to various scientific fields. His work has garnered attention for its innovative approach to liver cell regeneration, showcasing his expertise and dedication to advancing medical science.
Collaborations
Throughout his career, Wolfgang Strecker has collaborated with esteemed colleagues, including Gerhard Ruhenstroth-Bauer and Michel Goldberg. These collaborations have further enriched his research and contributed to the development of groundbreaking medical solutions.
Conclusion
Wolfgang Strecker's innovative work in enhancing liver growth through his patented drug exemplifies the potential of scientific research to improve health outcomes. His contributions to the field are significant and reflect a commitment to advancing medical knowledge.